جست‌وجوی استاد و پژوهشگر

Laura Schmuldtمشاهده پروفایل

دانشیار

• Clinical Mental Health Counseling
• Trauma Counseling
• Group Counseling
• +۹ مورد دیگر

Dr. Laura M. Schmuldt is an Associate Professor and Interim Department Chair in the Counseling Department at National Louis University. With over 25 years of clinical experience and 15 years in counselor education, she specializes in trauma counseling, group therapy, and women's mental health. Her work spans psychiatric rehabilitation, addiction treatment, and private practice, complemented by advanced training in EMDR and Dialectical Behavior Therapy. Ph.D., University of Central Florida: Counselor Education and Supervision M.A., Northeastern Illinois University: Counselor Education B.A., University of Illinois at Chicago: Psychology Dr. Schmuldt's research focuses on trauma counseling, abortion-related mental health, and EMDR adaptation for diverse populations. She integrates therapeutic documentation and curative factors into group counseling frameworks. Recent publications emphasize stress reduction, pandemic-era counseling, and the intersection of childhood abuse and addiction. Her presentations at national and international conferences highlight innovative applications of EMDR and DBT. Dr. Schmuldt serves as a Licensed Mental Health Counselor-Associate in North Carolina and is affiliated with organizations like the American Counseling Association and Association for Specialists in Group Work. Contact: lschmuldt@nl.edu | Office: 910-409-7773

Laura M. Schmuldtمشاهده پروفایل

دانشیار

• Clinical Mental Health Counseling
• Trauma Counseling
• Group Counseling
• +۶ مورد دیگر

Dr. Laura M. Schmuldt serves as the Interim Department Chair and Associate Professor in the Counseling Department, specializing in Clinical Mental Health Counseling, Trauma Counseling, and Group Counseling. She holds a Ph.D. in Counselor Education and Supervision from the University of Central Florida, an M.A. in Counselor Education from Northeastern Illinois University, and a B.A. in Psychology from the University of Illinois at Chicago. With over 25 years of counseling experience across psychiatric rehabilitation, addiction treatment, and private practice, she is also a Licensed Mental Health Counselor-Associate (LMHCA) in North Carolina. Her research focuses on trauma, women's mental health, abortion, anxiety, and the intersection of childhood abuse and addiction. She has presented at conferences globally and authored numerous publications on EMDR therapy, counselor supervision, and innovative teaching methods. Dr. Schmuldt is an active member of professional organizations such as the American Counseling Association and the Association for Counselor Education and Supervision. Her teaching spans virtual, hybrid, and in-person formats, emphasizing experiential learning and creative techniques. Notable contributions include developing the My Crime Card Sort for counselor education and pioneering EMDR approaches in crisis settings.

Bernhard Schmalenbachمشاهده پروفایل

استاد

• Special Education
• Inclusive Education
• Educational Science
• +۷ مورد دیگر

Prof. Bernhard Schmalenbach is a Professor of Special Education and Inclusive Education at Alanus University of Arts and Social Sciences (Alfter, Bonn) since 2008, and a lecturer in Inclusion at University of Bonn since 2017. His work focuses on curative education, autism research, phenomenology of corporeality, and the role of art in social professions. He holds a doctorate from the University of Cologne and has extensive experience in working with individuals with disabilities in Camphill communities. Educational Background: Studium der Heilpädagogik at University of Cologne Key Roles: Programme Director for Master of Arts in Special Education, Department of Educational Science Research interests include biographical research, support planning for individuals with disabilities, and Goethean phenomenological approaches to education. His publications span monographs, edited volumes, and journal articles on topics like diagnostic methods in special education and the anthropological significance of the hand in pedagogy. His recent articles (2020–2022) analyze needs assessment frameworks and the intersection of Waldorf pedagogy with philosophical methodologies. Despite prolific output, no scientific awards are explicitly mentioned. He advises multiple research projects and contributes to teacher training programs emphasizing art integration. Labs/Teams: Involved in research initiatives at Alanus University focusing on inclusive education and curriculum development.

Neil E. Kayمشاهده پروفایل

استاد

• Chronic Lymphocytic Leukemia (CLL)
• B-cell Biology
• Hematology
• +۱۲ مورد دیگر

Neil E. Kay, M.D., is a Professor of Medicine at Mayo Clinic in Rochester, Minnesota, where he serves as a Consultant in the Division of Hematology, Department of Internal Medicine, with a joint appointment in the Department of Immunology. His research is focused on chronic lymphocytic leukemia (CLL), particularly its biological and clinical heterogeneity, tumor microenvironment, B-cell signaling, and genomic evolution. Primary Appointment: Consultant, Division of Hematology, Department of Internal Medicine Joint Appointment: Consultant, Department of Immunology Academic Rank: Professor of Medicine Location: Mayo Clinic, Rochester, MN Dr. Kay has established a nationally recognized CLL tissue bank and clinical database that supports extensive translational and basic research. He collaborates with leading scientists at Mayo Clinic and beyond, including experts in immunology, pathology, epidemiology, and biostatistics. His research interests include: B-chronic lymphocytic leukemia (CLL) Tumor microenvironment and stromal interactions B-cell biology and signaling Genomic and epigenomic analysis of CLL clones Clonal evolution and risk stratification Development of novel therapies and clinical trials Recent publications reveal a strong focus on genomic characterization of CLL, particularly in underrepresented populations, mechanisms of therapy resistance, Richter transformation, and innovative approaches such as CAR-T cell modulation. His work increasingly integrates whole-genome sequencing, epidemiological data, and clinical trial outcomes to improve patient prognosis and personalize treatment. Scientific awards and leadership roles include: Member, Leukemia Steering Committee, National Cancer Institute Chairman, CLL Steering Committee, National Cancer Institute Member, Leukemia Core Committee, Eastern Cooperative Oncology Group Member, External Advisory Group (CLL), MD Anderson Cancer Center Section Editor, Leukemia Dr. Kay leads multiple active research grants from the National Cancer Institute and U.S. Army, focusing on predicting clinical outcomes and enhancing CAR-T cell safety. He has mentored numerous researchers and contributed over 500 peer-reviewed publications. His work is central to advancing understanding and treatment of CLL, with a vision toward curative strategies. He is involved in several laboratories and research programs at Mayo Clinic, including the Mayo Clinic Comprehensive Cancer Center, the Developmental Therapeutics Program, and collaborative networks such as the Eastern Cooperative Oncology Group and the CLL Working Group at the National Cancer Institute.

Alan D. Marmorsteinمشاهده پروفایل

استاد

• Regenerative Medicine
• Ophthalmology
• Retinal Degenerative Diseases
• +۹ مورد دیگر

Alan D. Marmorstein, Ph.D., is a Professor of Ophthalmology at Mayo Clinic in Rochester, Minnesota, where he holds the administrative title of Senior Associate Consultant II-Research in the Department of Ophthalmology. He is an active faculty member leading a research laboratory focused on regenerative medicine for retinal diseases. Ph.D., State University of New York Health Science Center at Brooklyn Postdoctoral Fellowship, Weill Cornell Medical College, Cornell University B.S. in Biology, State University of New York at Albany and City University of New York, College of Staten Island Dr. Marmorstein’s research is centered on preventing and restoring vision loss due to retinal degenerative diseases, particularly age-related and inherited macular degenerations such as Best disease and Doyne honeycomb retinal dystrophy. His lab employs a multidisciplinary, team-based approach involving animal models, stem cells, and collaboration with vitreoretinal surgeons and biomedical engineers. His three primary research areas include: understanding the pathogenesis of sub-RPE deposits in macular degeneration, developing iPSC-derived retinal pigment epithelium (RPE) cell therapies, and improving gene therapy delivery methods using hydrogel scaffolds. His work bridges basic science and clinical translation, aiming to develop curative or preventative treatments where none currently exist. His recent publications reflect a strong trend in regenerative ophthalmology, with a focus on iPSC-derived RPE transplantation, surgical delivery models, molecular mechanisms of bestrophin-1, and novel imaging and drug delivery systems. The research spans molecular biology, translational models, and clinical trial development, demonstrating a cohesive trajectory toward clinical application of cell and gene therapies for vision restoration. Scientific Awards and Editorial Roles: Fellow, Association for Research in Vision and Ophthalmology (2010) First-Round Award, Mayo Clinic President's Discovery Translation Program (2020) Associate Editor, Journal of Ocular Pharmacology and Therapeutics (2012–present) Member, Editorial Review Board, Molecular Vision (2010–present) Associate Editor, Frontiers in Cell and Developmental Biology (2021–present) Member, Editorial Board, PLOS ONE (2023–present) Dr. Marmorstein has secured multiple competitive grants from the National Eye Institute and Mayo Clinic to support his research on RPE cell therapy, bestrophin function, and retinal imaging. His projects include preclinical testing of iPSC-derived RPE for macular degeneration and clinical translation of stem cell-based therapies. He actively mentors researchers and collaborates across disciplines, contributing to both scientific advancement and training in regenerative ophthalmology. His laboratory is part of the Center for Regenerative Biotherapeutics at Mayo Clinic, where he leads a team focused on developing cell and gene therapies for retinal diseases. The lab integrates molecular biology, surgical innovation, and biomaterials to create comprehensive treatment platforms for macular degeneration.

Daniel Bauerمشاهده پروفایل

دانشیار

• Gene Therapy
• Genome Editing
• CRISPR-Cas9
• +۱۴ مورد دیگر

Daniel Bauer is a faculty member at Boston Children's Hospital and Dana-Farber Cancer and Blood Disorders Center, affiliated with Harvard Medical School in the Department of Hematology and Oncology. His research is centered on developing gene-editing therapies for blood disorders, particularly sickle cell disease and thalassemia. University: Boston Children's Hospital School: Harvard Medical School Department: Department of Hematology and Oncology Dr. Bauer’s research focuses on leveraging CRISPR and base editing technologies to reactivate fetal hemoglobin and correct genetic defects in hematopoietic stem cells. His work spans from mechanistic studies of hemoglobin switching regulators like BCL11A to translational applications in non-human primates and human cells. He has pioneered methods to improve editing efficiency, reduce genotoxicity, and develop safer delivery systems. His recent publications highlight a strong trend in refining gene-editing tools for clinical use—emphasizing in vivo delivery, off-target assessment, prime editing optimization, and culture-free editing to preserve stem cell function. These studies demonstrate a clear trajectory toward curative therapies for hemoglobinopathies. Dr. Bauer has mentored trainees and led a productive research program, though specific student names and awards are not listed in the provided text. He has secured research funding to support his lab’s work in genome editing and therapeutic development. He leads a research team focused on genetic medicine for blood disorders, integrating molecular biology, genomics, and preclinical models to advance gene therapy. His lab is actively involved in both basic and translational research, aiming to bridge the gap between bench discoveries and clinical applications.

Maximilian Buchkaمشاهده پروفایل

استاد

• Special Education
• Childhood Development
• Social Pedagogy
• +۴ مورد دیگر

Maximilian Buchka is a Professor of Special and Childhood Education at Katholische Hochschule Nordrhein-Westfalen in Köln. His academic career spans over 26 years, during which he also served as Dean, Prorector for Studies and Teaching, and Acting Rector. He holds a doctoral degree in Special Education, with minors in School Education and Religious Education. His work focuses on special education, social pedagogy, and anthroposophical approaches to education and therapy. Education: Teacher training in primary/secondary and special education; doctoral studies in Aachen, Bonn, Köln, and Dortmund. Research Interests: Special education for intellectual disabilities, aging with disabilities, inclusive education, and anthroposophical pedagogy. He has authored numerous books, including Das Alter. Heil- und sozialpädagogische Konzepte (2011) and Ältere Menschen mit geistiger Behinderung (2003). His work emphasizes holistic approaches to education and care, integrating interdisciplinary methods. Recipient of the Golden Comenius Medal (2009) and the Merit Award from Katholische Hochschule Köln (2010). He has also held visiting professor roles at the Comenius University in Bratislava since 2016.

Mone Welscheمشاهده پروفایل

استاد

• Movement and Sport Education
• Curative Education
• Mental Illnesses in Childhood and Adolescence
• +۳ مورد دیگر

Prof. Mone Welsche is a Professor for Developmental Support in Childhood and Adolescence at KH Freiburg. Their academic background includes a PhD in Movement Sciences from the University of Hamburg (Doctor of Sport Sciences), an M.A. in Somatic Studies and Laban Analysis from the University of Surrey (UK), and a Diploma in Special Education and Rehabilitation from the University of Dortmund, focusing on movement education and therapy. Professional Career Highlights: 2010–present: Full Professor at KH Freiburg 2004–2010: Junior Professor at the University of Hamburg (Movement and Sport Education with a focus on Movement Diagnosis and Counseling) 2009–2010: Freelance lecturer, movement analyst (e.g., FU Berlin research project on "Gestures in Alexithymia"), and certified pedagogue 2007–2009: Movement therapist and pedagogue at the Martin-Gropius-Eberswalde Clinic for Child and Adolescent Psychiatry and Psychotherapy, specializing in therapy conceptualization and parent support Research focuses on movement-based approaches in curative education, mental health interventions for youth, and developmental support strategies. Expertise spans interdisciplinary therapy integration (music, art, movement), diagnosis, and family-oriented therapeutic interventions.

Nathan R. Georgeمشاهده پروفایل

عضو هیئت علمی

• Developmental Psychology
• Cognitive Psychology
• Language Acquisition
• +۹ مورد دیگر

Nathan R. George is an Assistant Teaching Professor in the Department of Psychology at the Gordon F. Derner School of Psychology, Adelphi University. He holds a Ph.D. in Developmental Psychology from Temple University (2014) and a B.S. in Psychology from Lehigh University (2008). He is actively involved in teaching, research, and mentoring students at both undergraduate and graduate levels. Ph.D., Developmental Psychology, Temple University (2014) B.S., Psychology, Lehigh University (2008) His research centers on children's cognitive and linguistic development, particularly focusing on language acquisition, event perception, bilingualism, and the interplay between language and thought. He explores how children learn verbs, understand force and motion, and develop causal reasoning, with a growing interest in the cognitive benefits of board games. His work often involves cross-linguistic comparisons and collaborations with international researchers in the Netherlands and Turkey. The majority of his recent publications and student-led research projects reflect a strong trend in experimental developmental psychology, with emphasis on statistical learning, bilingual cognition, and real-world applications of psychological science. His research has been supported by internal grants, including Faculty Development Grants for projects on verb learning and language's influence on physics understanding. 2022-2023 Undergraduate Psychology Club Professor of the Year 2019-2020 Adelphi University Teaching Fellow Multiple prior Professor of the Year awards (2016–2018) Dr. George is a dedicated mentor, having chaired doctoral dissertations, advised numerous honors theses, and supervised independent studies and summer research fellows. He is actively involved in university service, including curriculum development, accreditation, and conference organization. He also mentors students through the Psychology Club and Psi Chi, and serves on multiple university and departmental committees. His lab and research team include a diverse group of undergraduate and graduate students engaged in projects on bilingualism, false memory, board games, and language development. He emphasizes hands-on, experiential research training and encourages students to present at national conferences such as SRCD, APA, and CUR.

• Paediatric Neurology
• Neurogenetics
• Cerebral Palsy
• +۷ مورد دیگر

Professor Michael Fahey is a leading academic and clinician in paediatric neurology and neurogenetics at Monash University, affiliated with the School of Clinical Sciences at Monash Health and based at Monash Medical Centre. He serves as Head of the Paediatric Neurology Unit and is actively involved in clinical care, research, and training. University: Monash University School: School of Clinical Sciences at Monash Health Department: Paediatrics Academic Rank: Professor His research is centered on neurogenetics, with a focus on understanding the genetic causes of cerebral palsy, developmental and epileptic encephalopathies, movement disorders, and rare neurometabolic diseases. He aims to transition from disease management to curative therapies through genetic insights. His recent publications and ongoing clinical trials highlight a strong trend in translational neuroscience, particularly in gene discovery, pharmacological interventions (e.g., valbenazine, LP352), and novel therapies like mitochondrial donation and medicinal cannabis. His work bridges molecular genetics with clinical neurology, emphasizing early diagnosis and targeted treatments. Fulbright Scholarship (2018) Professor Fahey leads multiple research grants and clinical trials, including a Phase 3 study on valbenazine for dyskinesia in cerebral palsy and the MitoHOPE program on mitochondrial donation. He collaborates extensively with institutions such as the Ritchie Centre, Murdoch Children’s Research Institute, Alfred Hospital, and Royal Melbourne Hospital. He supervises research in neurology, neurogenetics, and cerebral palsy, though specific student names are not listed. He co-founded a mitochondrial clinic and is integral to neurogenetics clinics at Royal Melbourne and St Vincents Hospitals. His work is supported by a robust network of clinical and research teams focused on improving outcomes for children with neurological and genetic disorders.

Daniel Hollernمشاهده پروفایل

استادیار

• Cancer Immunology
• Breast Cancer Research
• Tumor-Immune Cell Interactions
• +۳ مورد دیگر

Daniel Hollern is an Assistant Professor at the Salk Institute for Biological Studies, where he leads the Hollern Lab within the NOMIS Center for Immunobiology and Microbial Pathogenesis. His research focuses on understanding tumor-immune cell interactions, with particular emphasis on B cells in cancer immunity. Dr. Hollern's educational background includes a PhD in Cell and Molecular Biology from Michigan State University, postdoctoral training at the University of North Carolina, and a Bachelor of Science in Biology from Grand Valley State University. Hollern's research interests center on cancer immunology, specifically investigating how B cells contribute to anti-tumor immune responses. His lab has made groundbreaking discoveries showing that B cells are key regulators of response to immune checkpoint inhibitors, particularly in triple-negative breast cancer. His work demonstrates that patients with tumor-infiltrating B cells have higher response rates to chemotherapy and immunotherapy. The lab's research explores B cell interactions with CD4+ T cells, antibody production against tumor cells, and the mechanisms by which B cells drive curative responses to immunotherapy. Current investigations focus on leveraging B cells therapeutically to improve cancer treatment outcomes. Analysis of Dr. Hollern's recent publications reveals a consistent focus on B cell immunology in cancer, with particular emphasis on triple-negative breast cancer. His work spans basic immunological mechanisms, translational applications, and clinical implications of B cell activity in tumor microenvironments. The research demonstrates how B cells interact with other immune components like T follicular helper cells and interleukin 21 to mediate anti-tumor responses. 2019 Joseph Pagano Award 2015 NIH NCI F32 Ruth L. Kirschstein National Research Service Award 2014 NIH NCI F31 Ruth L. Kirschstein National Research Service Award 2014 Aitch Foundation Award The Hollern Lab maintains a strong focus on mentoring and collaboration, emphasizing diversity, inclusion, and equitable scientific practices. The lab culture prioritizes building a supportive environment for tackling complex cancer research questions through interdisciplinary approaches. Dr. Hollern's research program represents a significant contribution to understanding how to harness the immune system, particularly B cells, to develop more effective cancer treatments with long-term disease control.